Edesa Biotech, Inc. - 8-K Filing

European Commission grants orphan drug designation to paridiprubart for Acute Respiratory Distress Syndrome (ARDS) treatment. (Items: 8.01 Other Events)

SEC EDGAR ·

Read the full article at SEC EDGAR

More Regulatory news